Search - tctmd.com

Displaying 21 - 40 of 521

Sort: Relevancy | Date

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

May 16, 2025

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

April 23, 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

News Conference News EHRA 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

March 31, 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

March 29, 2025

What’s Going to Be Hot at ACC 2025?

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

March 06, 2025

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

February 14, 2025

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

News Conference News STS 2025

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

Yael L. Maxwell

January 31, 2025

Top Endovascular News of 2024

News Daily News

Top Endovascular News of 2024

December 28, 2024

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

December 04, 2024

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

December 03, 2024

November 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

November 26, 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

November 11, 2024

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

November 06, 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

October 29, 2024

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

News Daily News

Standing Alone Will Not Offset Sitting’s CVD Risks, Study Suggests

October 21, 2024

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

October 08, 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

News Conference News ESC 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

September 02, 2024

Scientific Statement Reviews Current Antithrombotic Options in PAD

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

August 26, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.